The study provides insights into how the cancers resist treatments, and which patients may benefit from treatment.
MAGENTA study also found no increased stress among test subjects who did not receive pre- and post-test counseling with their results.
There is currently no way to detect ovarian cancer early. But genetic testing enables doctors to identify a person's risk and may help prevent the cancer.
Findings on nearly 4,000 BRCA1 mutations will be immediately useful to many patients with previously inconclusive genetic test results.
This KING5 video looks at a free home genetic test for women who are at risk for ovarian cancer is available through MAGENTA, which s short for MAking GENetic Testing Accessible
In patient referrals, primary care physicians are influenced by their own connections to the disease, study suggests.
A free home genetic test for women who are at risk for ovarian cancer is available through MAGENTA, which s short for MAking GENetic Testing Accessible.
In a study of 36 women – 16 diagnosed with ovarian cancer and a control group of 20 with no cancer diagnosis – nearly all of the women were found to carry cancer-associated gene mutations.
A national alliance of cancer-focused groups today announced the formation of a "dream team" dedicated to ovarian cancer research, and investment of $6 million over three years to pursue therapies.
Fifty-seven percent of physicians correctly assessed female patients’ risk for ovarian cancer and 62 percent correctly assessed their risk for colon cancer in a